The most common cancer types tested for TIM‐3 expression were colorectal cancer (N = 140) followed by pancreatic cancer (N = 55), breast cancer (N = 49), and ovarian cancer (N = 43). This evidence concerns the gene HAVCR2 and breast cancer.